New Studies Do Not Challenge the American College of Cardiology/American Heart Association Lipid Guidelines

Ann Intern Med. 2016 May 17;164(10):683-4. doi: 10.7326/M15-2428. Epub 2016 Feb 9.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • American Heart Association
  • Anticholesteremic Agents / therapeutic use
  • Cardiology
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood*
  • Ezetimibe / therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / drug therapy
  • Practice Guidelines as Topic*
  • Proprotein Convertase 9 / antagonists & inhibitors
  • Proprotein Convertase 9 / immunology
  • Risk Factors
  • Societies, Medical
  • United States

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Ezetimibe